Cartesian Therapeutics, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2017 | — | -10,789.8% | -11,046.7% |
| Jun 2017 | — | -61,042.3% | -61,411.5% |
| Sep 2017 | — | -51,311.1% | -54,355.6% |
| Dec 2017 | — | -113,394.1% | -114,964.7% |
| Dec 2018 | — | -1,605.6% | -1,622.5% |
| Mar 2019 | — | -118,560.0% | -120,740.0% |
| Jun 2019 | — | -124,884.6% | -126,107.7% |
| Dec 2019 | — | -188.9% | -223.7% |
| Sep 2020 | — | -295.6% | -209.4% |
| Dec 2020 | — | -66.1% | -129.2% |
| Mar 2021 | — | -64.8% | -222.6% |
| Jun 2021 | — | 2.3% | 23.2% |
| Sep 2021 | — | -8.1% | -73.3% |
| Dec 2021 | — | 13.6% | 40.9% |
| Mar 2022 | — | 31.7% | 84.6% |
| Jun 2022 | — | 35.3% | 21.9% |
| Sep 2022 | — | -7.7% | -38.1% |
| Dec 2022 | — | -50.6% | 35.1% |
| Mar 2023 | — | -309.5% | -364.8% |
| Jun 2023 | — | -355.1% | -216.9% |
| Sep 2023 | — | -199.4% | -137.4% |
| Dec 2023 | — | -439.5% | -2,149.3% |
| Mar 2024 | — | -228.6% | -973.0% |
| Jun 2024 | — | 41.1% | 41.4% |
| Sep 2024 | — | -4,541.3% | -6,248.8% |
| Dec 2024 | — | 3,521.9% | 1,350.9% |
| Mar 2025 | — | -1,989.9% | -1,610.0% |
| Jun 2025 | — | -7,319.1% | 5,330.9% |
| Sep 2025 | — | -4,660.6% | -7,942.9% |
| Dec 2025 | — | -8,304.0% | -9,775.7% |
| Mar 2026 | — | -33,973.1% | -50,233.3% |